Medical communications and marketing agency


OaklinsDealFlash_MedicalCommunicationsAndMarketingAgency_Media_Dec2015 picOaklins’ media specialist team in New York acted as the exclusive financial advisor to the shareholders of Symbiotix, Inc. in the sale of the company to Havas Health, Inc., a world leading healthcare marketing network and a subsidiary company of Havas.

The team worked with management to define the marketplace positioning for Symbiotix Inc. and prepare the offering memorandum and other materials. Over 90 prospective buyers were contacted and the team led discussions with all parties and negotiated the deal with Havas Health.

Read more about the transaction, market trends, deal drivers and M&A valuation aspects in the attached newsletter.